IDiyas

For the Inventor, By the Inventor

Harpenden, United Kingdom

Joseph A Martin

USPTO Granted Patents = 18

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 253(Granted Patents)


Location History:

  • West Common, GB (1997)
  • Harpenden, GB (1983 - 2000)

Company Filing History:

goldMedal18 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1983-2000

Loading Chart...
18 patents (USPTO):Explore Patents
1. 6162918 - Xanthene and acridine derivatives (2000-12-19),
2. 5969139 - Acridine derivatives (1999-10-19),
3. 5705492 - 3'-O-aminoacyl ARA uridines, method of making, and antiviral activity (1998-01-06),
4. 5698532 - Pyrimidine nucleosides and methods for treating viral infections with (1997-12-16),
5. 5652369 - Amino acid derivatives (1997-07-29),
6. 5620987 - Amino acid derivatives (1997-04-15),
7. 5583248 - Amino acid derivatives having antiviral activity (1996-12-10),
8. 5554756 - Amino acid derivatives (1996-09-10),
9. 5446161 - Amino acid derivatives (1995-08-29),
10. 5430041 - Amino acid derivatives having antiviral activity (1995-07-04),
11. 5196438 - Amino acid derivatives (1993-03-23),
12. 5157041 - Amino acid derivatives (1992-10-20),
13. 5010060 - Method of treating herpes simplex viral infection employing pyrimidine (1991-04-23),
14. 4956346 - Pyrimidine derivatives as an antiviral agent (1990-09-11),
15. 4886785 - Pyrimidine derivatives, pharmaceutical compositions and method of using (1989-12-12),

Title: Joseph A Martin: Innovator in Pharmaceutical Chemistry

Introduction

Joseph A Martin is a distinguished inventor based in Harpenden, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 18 patents. His work primarily focuses on developing innovative compounds that have therapeutic applications.

Latest Patents

Among his latest patents are the inventions related to xanthene and acridine derivatives. The xanthene derivatives invention pertains to new and known tricyclic dione derivatives that act as inhibitors of herpes simplex virus thymidine kinase. This innovation is crucial for the treatment and prophylaxis of infections caused by the herpes simplex virus. Additionally, his work on acridine derivatives also involves tricyclic dione derivatives, showcasing his expertise in creating compounds with potential medical benefits.

Career Highlights

Joseph A Martin is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company allows him to further his research and development efforts in creating effective therapeutic agents. His extensive experience and innovative mindset have positioned him as a key player in his field.

Collaborations

Throughout his career, Joseph has collaborated with notable colleagues, including Gareth J Thomas and Sally Redshaw. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Joseph A Martin's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to innovation in the field. His work continues to impact the treatment of viral infections, showcasing the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…